About Kristopher Hanson
Kristopher Hanson is a general counsel at MapLight Therapeutics.
Kristopher Hanson reports to the SEC as an officer of 2 public companies, including PhaseBio Pharmaceuticals (PHAS).
Kristopher Hanson first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Kristopher Hanson in the role, so the role may have started earlier or lasted longer.
PI
PhaseBio Pharmaceuticals Inc
SVP and General Counsel
2019 – 2022 · Public company (PHAS)
Key Colleagues at Startups
The people Kristopher Hanson works with at each company, as listed on that company's latest Form D.
MapLight Therapeutics, Inc. · Form D, Jul 28, 2025
TG
Timothy Garnett
Director
GP
George Pavlov
Director
PB
Peter Bisgaard
Director
EF
Erin Foff
Executive officer
AK
Anatol Kreitzer
Executive officer
JT
Jim Trenkle
Director
JL
James Lillie
Executive officer
MW
Maria Walker
Director
CK
Christopher Kroeger
Chief Executive Officer and director
JG
Jonathan Gillis
Executive officer
VS
Vishwas Setia
Executive officer
NL
Nanna Luneborg
Director